Literature DB >> 11003647

Essential roles for ankyrin repeat and transactivation domains in induction of T-cell leukemia by notch1.

J C Aster1, L Xu, F G Karnell, V Patriub, J C Pui, W S Pear.   

Abstract

Notch receptors participate in a conserved signaling pathway that controls the development of diverse tissues and cell types, including lymphoid cells. Signaling is normally initiated through one or more ligand-mediated proteolytic cleavages that permit nuclear translocation of the intracellular portion of the Notch receptor (ICN), which then binds and activates transcription factors of the Su(H)/CBF1 family. Several mammalian Notch receptors are oncogenic when constitutively active, including Notch1, a gene initially identified based on its involvement in a (7;9) chromosomal translocation found in sporadic T-cell lymphoblastic leukemias and lymphomas (T-ALL). To investigate which portions of ICN1 contribute to transformation, we performed a structure-transformation analysis using a robust murine bone marrow reconstitution assay. Both the ankyrin repeat and C-terminal transactivation domains were required for T-cell leukemogenesis, whereas the N-terminal RAM domain and a C-terminal domain that includes a PEST sequence were nonessential. Induction of T-ALL correlated with the transactivation activity of each Notch1 polypeptide when fused to the DNA-binding domain of GAL4, with the exception of polypeptides deleted of the ankyrin repeats, which lacked transforming activity while retaining strong transactivation activity. Transforming polypeptides also demonstrated moderate to strong activation of the Su(H)/CBF1-sensitive HES-1 promoter, while polypeptides with weak or absent activity on this promoter failed to cause leukemia. These experiments define a minimal transforming region for Notch1 in T-cell progenitors and suggest that leukemogenic signaling involves recruitment of transcriptional coactivators to ICN1 nuclear complexes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11003647      PMCID: PMC86303          DOI: 10.1128/MCB.20.20.7505-7515.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  54 in total

1.  Neoplastic transformation by Notch is independent of transcriptional activation by RBP-J signalling.

Authors:  E Dumont; K P Fuchs; G Bommer; B Christoph; E Kremmer; B Kempkes
Journal:  Oncogene       Date:  2000-01-27       Impact factor: 9.867

2.  SKIP, a CBF1-associated protein, interacts with the ankyrin repeat domain of NotchIC To facilitate NotchIC function.

Authors:  S Zhou; M Fujimuro; J J Hsieh; L Chen; A Miyamoto; G Weinmaster; S D Hayward
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

3.  Signaling in leukemia: which messenger to kill?

Authors:  W S Pear
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

4.  LAG-3 is a putative transcriptional activator in the C. elegans Notch pathway.

Authors:  A G Petcherski; J Kimble
Journal:  Nature       Date:  2000-05-18       Impact factor: 49.962

5.  Functional interaction between the mouse notch1 intracellular region and histone acetyltransferases PCAF and GCN5.

Authors:  H Kurooka; T Honjo
Journal:  J Biol Chem       Date:  2000-06-02       Impact factor: 5.157

6.  Embryonic lethality in mice homozygous for a processing-deficient allele of Notch1.

Authors:  S S Huppert; A Le; E H Schroeter; J S Mumm; M T Saxena; L A Milner; R Kopan
Journal:  Nature       Date:  2000-06-22       Impact factor: 49.962

7.  Neoplastic transformation by Notch requires nuclear localization.

Authors:  S Jeffries; A J Capobianco
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

8.  A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1.

Authors:  J S Mumm; E H Schroeter; M T Saxena; A Griesemer; X Tian; D J Pan; W J Ray; R Kopan
Journal:  Mol Cell       Date:  2000-02       Impact factor: 17.970

9.  Suppressor of Hairless-independent events in Notch signaling imply novel pathway elements.

Authors:  K Matsuno; M J Go; X Sun; D S Eastman; S Artavanis-Tsakonas
Journal:  Development       Date:  1997-11       Impact factor: 6.868

10.  Notch signalling is required for cyclic expression of the hairy-like gene HES1 in the presomitic mesoderm.

Authors:  C Jouve; I Palmeirim; D Henrique; J Beckers; A Gossler; D Ish-Horowicz; O Pourquié
Journal:  Development       Date:  2000-04       Impact factor: 6.868

View more
  111 in total

1.  Cutaneous β-human papillomavirus E6 proteins bind Mastermind-like coactivators and repress Notch signaling.

Authors:  Min Jie Alvin Tan; Elizabeth A White; Mathew E Sowa; J Wade Harper; Jon C Aster; Peter M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-30       Impact factor: 11.205

2.  Deletion-based mechanisms of Notch1 activation in T-ALL: key roles for RAG recombinase and a conserved internal translational start site in Notch1.

Authors:  Todd D Ashworth; Warren S Pear; Mark Y Chiang; Stephen C Blacklow; Jérôme Mastio; Lanwei Xu; Michelle Kelliher; Philippe Kastner; Susan Chan; Jon C Aster
Journal:  Blood       Date:  2010-09-17       Impact factor: 22.113

3.  Notch signaling is a potent inducer of growth arrest and apoptosis in a wide range of B-cell malignancies.

Authors:  Patrick A Zweidler-McKay; Yiping He; Lanwei Xu; Carlos G Rodriguez; Fredrick G Karnell; Andrea C Carpenter; Jon C Aster; David Allman; Warren S Pear
Journal:  Blood       Date:  2005-08-23       Impact factor: 22.113

Review 4.  Notch and the regulation of osteoclast differentiation and function.

Authors:  Jungeun Yu; Ernesto Canalis
Journal:  Bone       Date:  2020-06-08       Impact factor: 4.398

5.  Amplification of NOTCH1 and ABL1 gene loci is a frequent aberration in enteropathy-type T-cell lymphoma.

Authors:  Pavlina Cejkova; Andreas Zettl; Anne K Baumgärtner; Andreas Chott; German Ott; Hans Konrad Müller-Hermelink; Petr Starostik
Journal:  Virchows Arch       Date:  2005-03-09       Impact factor: 4.064

6.  Notch subunit heterodimerization and prevention of ligand-independent proteolytic activation depend, respectively, on a novel domain and the LNR repeats.

Authors:  Cheryll Sanchez-Irizarry; Andrea C Carpenter; Andrew P Weng; Warren S Pear; Jon C Aster; Stephen C Blacklow
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

7.  Identification of a conserved negative regulatory sequence that influences the leukemogenic activity of NOTCH1.

Authors:  Mark Y Chiang; Mina L Xu; Gavin Histen; Olga Shestova; Monideepa Roy; Yunsun Nam; Stephen C Blacklow; David B Sacks; Warren S Pear; Jon C Aster
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

8.  OLIG2 (BHLHB1), a bHLH transcription factor, contributes to leukemogenesis in concert with LMO1.

Authors:  Ying-Wei Lin; Ramona Deveney; Mary Barbara; Norman N Iscove; Stephen D Nimer; Christopher Slape; Peter D Aplan
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

9.  Heterozygosity for hypoxia inducible factor 1alpha decreases the incidence of thymic lymphomas in a p53 mutant mouse model.

Authors:  Jessica A Bertout; Shetal A Patel; Benjamin H Fryer; Amy C Durham; Kelly L Covello; Kenneth P Olive; Michael H Goldschmidt; M Celeste Simon
Journal:  Cancer Res       Date:  2009-03-17       Impact factor: 12.701

10.  Direct inhibition of the NOTCH transcription factor complex.

Authors:  Raymond E Moellering; Melanie Cornejo; Tina N Davis; Cristina Del Bianco; Jon C Aster; Stephen C Blacklow; Andrew L Kung; D Gary Gilliland; Gregory L Verdine; James E Bradner
Journal:  Nature       Date:  2009-11-12       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.